Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 12, 2015
Clinical News

Xyrem sodium oxybate: Phase III started

BioCentury | Dec 24, 2012
Clinical News

Xyrem sodium oxybate regulatory update

BioCentury | May 7, 2012
Strategy

Jazz's big band sound

Jazz continues specialty acquisition strategy, but will shift focus to R&D buys
BioCentury | Oct 24, 2011
Clinical News

Xyrem sodium oxybate regulatory update

BioCentury | May 9, 2011
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | May 9, 2011
Clinical News

Sodium oxybate: Development discontinued

BioCentury | May 4, 2011
Company News

Jazz drops fibromyalgia plans

BioCentury | Mar 21, 2011
Clinical News

Xyrem sodium oxybate regulatory update

BioCentury | Feb 7, 2011
Clinical News

Xyrem sodium oxybate regulatory update

Items per page:
1 - 10 of 61
Help Center
Username
Request a Demo
Request Training
Ask a Question